What's New on the FDA Drugs Site
May 15, 2015
- FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
- FDA Issues Letters to Doctors Who May Have Purchased Counterfeit or Unapproved Prescription Drugs
- From our perspective: The U.S. drug supply chain and patient safety
- Drug Trials Snapshot: Corlanor
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Orange Book (updated)
- National Drug Code Directory
No hay comentarios:
Publicar un comentario